--11 Communities across Canada to Take Part in Multiple Myeloma Marches
during Blood Cancer Awareness Month--
MONTREAL, Sept. 18, 2012 /CNW Telbec/ - This month, people in 11
locations across six provinces will be marching together to "make
myeloma matter". Myeloma, also called multiple myeloma, is a blood
cancer that affects cells in the bone marrow. Seven new cases are
diagnosed each day in Canada and the disease remains incurable, but new
treatments are providing new hope for patients. The Marches will take
place on September 23rd and 30th. September is national blood cancer month in Canada.
"It's essential for patients to know about treatment advances including
drugs such as Revlimid and Velcade that are dramatically changing
lives", said Aldo Del Col, Co-founder & Executive Director of Myeloma
Canada. "Dr. Donna Reece at Princess Margaret Hospital in Toronto has
even reported that newer, more tolerable drugs can be used for
long-term maintenance therapy that may eventually transform myeloma
into a chronic disease. Nevertheless, myeloma is not curable and we
need to support more research and fight for approval of even newer
drugs as they become available".
The Marches began in 2009 in Montreal, expanded to six cities last year,
and this year will take place in 11 communities across Canada led by
patients, families and friends, each with a dramatic story of courage
In Saskatoon the March is led by the family of George Ferguson who was
hospitalized for more than three months with life threatening
complications after he was diagnosed in May 2010. Since then, thanks to
promising new treatments, he celebrated his son's wedding this year.
In Winnipeg, Heidy Foot says "life is a journey…sometimes we can choose
the path we want to take and sometimes we are forced to take a certain
path due to illness or family circumstance". Heidy's path leads her to
march in honour of her Aunt Maggie who has been battling myeloma for
the past six years.
In Quebec sisters Laurie and Maude Carrier will lead the March in honour
of their father, who was near death in the emergency room by the time
he was diagnosed. He too has overcome many obstacles since his
diagnosis, and the family says Myeloma Canada gave them "unwavering
hope", as they struggled to return to normal lives.
In Windsor-Essex County, Emma Roung asks, "why should we care about this
disease with the unfamiliar name? Because, when my husband was
diagnosed in 2010 we had trouble getting information even from health
professionals. So I am leading a March to raise awareness in memory of
my husband and on behalf of the nearly 50 Canadians diagnosed with
myeloma every week".
These and other patient stories personify winning strategies in the
fight against cancer that Dr. Andrew Belch of the Cross Cancer
Institute in Edmonton has described as "finally moving the goal posts"
in treating myeloma.
The first March was held this year on September 16th in Halifax. Upcoming Marches will be held on September 23rd in Mississauga, Ottawa-Gatineau, Saskatoon, Sault Ste. Marie, St.
John's and Winnipeg; and on September 30th in Montreal, Quebec City, Saguenay and Windsor Essex-County. Details
can be found at www.myelomamarch.ca.
About Myeloma Canada
Myeloma Canada is the only national organization exclusively devoted to
the Canadian myeloma community. As a patient-driven, patient-focused
organization, Myeloma Canada has been making myeloma matter since 2004,
working with leading myeloma researchers and clinicians as well as
other cancer organizations and local support groups across Canada.
Myeloma Canada seeks to strengthen the voice of the Canadian myeloma
community and improve the quality of life of myeloma patients, their
caregivers and families through education, awareness, advocacy and
Myeloma Canada is making myeloma matter for the over 7,000 Canadians
affected by this incurable, yet increasingly treatable cancer by:
Providing educational resources and support to patients, their families
Increasing awareness of the disease and its effects on the lives of
patients and families
Advancing research and promoting access to new drug trials in Canada
Facilitating access to new therapies, treatment options and health care
About Multiple Myeloma
Multiple myeloma (or simply myeloma) is a rare cancer of the bone marrow
affecting production of red cells, white cells and platelets, and can
lead to anaemia, infections, renal failure, bone damage and severe
pain. Every day, seven more Canadians are diagnosed with this incurable
but increasingly treatable cancer.
New drugs have been successful in extending the lives of patients, but
the reality is that myeloma remains a fatal disease and more needs to
be done to advance the search for a cure.
SOURCE: MYELOMA CANADA
For further information:
T: 514-426-5885 or T: 1-888-798-5771